Cargando…

Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory

BACKGROUND: The autoverification system for coagulation consists of a series of rules that allow normal data to be released without manual verification. With new advances in medical informatics, the laboratory information system (LIS) has growing potential for the autoverification, allowing rapid an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhongqing, Peng, Cheng, Kang, Hui, Fan, Xia, Mu, Runqing, Zhou, Liping, He, Miao, Qu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609390/
https://www.ncbi.nlm.nih.gov/pubmed/31269951
http://dx.doi.org/10.1186/s12911-019-0848-2
_version_ 1783432308226785280
author Wang, Zhongqing
Peng, Cheng
Kang, Hui
Fan, Xia
Mu, Runqing
Zhou, Liping
He, Miao
Qu, Bo
author_facet Wang, Zhongqing
Peng, Cheng
Kang, Hui
Fan, Xia
Mu, Runqing
Zhou, Liping
He, Miao
Qu, Bo
author_sort Wang, Zhongqing
collection PubMed
description BACKGROUND: The autoverification system for coagulation consists of a series of rules that allow normal data to be released without manual verification. With new advances in medical informatics, the laboratory information system (LIS) has growing potential for the autoverification, allowing rapid and accurate verification of clinical laboratory tests. The purpose of the study is to develop and evaluate a LIS-based autoverification system for validation and efficiency. METHODS: Autoverification decision rules, including quality control, analytical error flag, critical value, limited range check, delta check and logical check, as well as patient’s historical information, were integrated into the LIS. Autoverification limited range was constructed based on 5 and 95% percentiles. The four most commonly used coagulation assays, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen (FBG), were followed by the autoverification protocols. The validation was assessed by the autoverification passing rate, the true-positive cases, the true-negative cases, the false-positive cases, the false-negative cases, the sensitivity and the specificity; the efficiency was evaluated in the turnaround time (TAT). RESULTS: A total of 157,079 historical test results of coagulation profiles from January 2016 to December 2016 were collected to determine the distribution intervals. The autoverification passing rate was 77.11% (29,165/37,821) based on historical patient data. In the initial test of the autoverification version in June 2017, the overall autoverification passing rate for the whole sample was 78.75% (11,257/14,295), with 892 true-positive cases, 11,257 true-negative cases, 2146 false-positive cases, no false-negative cases, sensitivity of 100% and specificity of 83.99%. After formal implementation of the autoverification system for 6 months, 83,699 samples were assessed. The average overall autoverification passing rate for the whole sample was 78.86% and the 95% confidence interval (CI) of the passing rate was [78.25, 79.59%]. TAT was reduced from 126 min to 101 min, which was statistically significant (P < 0.001, Mann-Whitney U test). CONCLUSIONS: The autoverification system for coagulation assays based on LIS can halt the samples with abnormal values for manual verification, guarantee medical safety, minimize the requirements for manual work, shorten TAT and raise working efficiency.
format Online
Article
Text
id pubmed-6609390
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66093902019-07-16 Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory Wang, Zhongqing Peng, Cheng Kang, Hui Fan, Xia Mu, Runqing Zhou, Liping He, Miao Qu, Bo BMC Med Inform Decis Mak Research Article BACKGROUND: The autoverification system for coagulation consists of a series of rules that allow normal data to be released without manual verification. With new advances in medical informatics, the laboratory information system (LIS) has growing potential for the autoverification, allowing rapid and accurate verification of clinical laboratory tests. The purpose of the study is to develop and evaluate a LIS-based autoverification system for validation and efficiency. METHODS: Autoverification decision rules, including quality control, analytical error flag, critical value, limited range check, delta check and logical check, as well as patient’s historical information, were integrated into the LIS. Autoverification limited range was constructed based on 5 and 95% percentiles. The four most commonly used coagulation assays, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen (FBG), were followed by the autoverification protocols. The validation was assessed by the autoverification passing rate, the true-positive cases, the true-negative cases, the false-positive cases, the false-negative cases, the sensitivity and the specificity; the efficiency was evaluated in the turnaround time (TAT). RESULTS: A total of 157,079 historical test results of coagulation profiles from January 2016 to December 2016 were collected to determine the distribution intervals. The autoverification passing rate was 77.11% (29,165/37,821) based on historical patient data. In the initial test of the autoverification version in June 2017, the overall autoverification passing rate for the whole sample was 78.75% (11,257/14,295), with 892 true-positive cases, 11,257 true-negative cases, 2146 false-positive cases, no false-negative cases, sensitivity of 100% and specificity of 83.99%. After formal implementation of the autoverification system for 6 months, 83,699 samples were assessed. The average overall autoverification passing rate for the whole sample was 78.86% and the 95% confidence interval (CI) of the passing rate was [78.25, 79.59%]. TAT was reduced from 126 min to 101 min, which was statistically significant (P < 0.001, Mann-Whitney U test). CONCLUSIONS: The autoverification system for coagulation assays based on LIS can halt the samples with abnormal values for manual verification, guarantee medical safety, minimize the requirements for manual work, shorten TAT and raise working efficiency. BioMed Central 2019-07-03 /pmc/articles/PMC6609390/ /pubmed/31269951 http://dx.doi.org/10.1186/s12911-019-0848-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Zhongqing
Peng, Cheng
Kang, Hui
Fan, Xia
Mu, Runqing
Zhou, Liping
He, Miao
Qu, Bo
Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory
title Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory
title_full Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory
title_fullStr Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory
title_full_unstemmed Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory
title_short Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory
title_sort design and evaluation of a lis-based autoverification system for coagulation assays in a core clinical laboratory
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609390/
https://www.ncbi.nlm.nih.gov/pubmed/31269951
http://dx.doi.org/10.1186/s12911-019-0848-2
work_keys_str_mv AT wangzhongqing designandevaluationofalisbasedautoverificationsystemforcoagulationassaysinacoreclinicallaboratory
AT pengcheng designandevaluationofalisbasedautoverificationsystemforcoagulationassaysinacoreclinicallaboratory
AT kanghui designandevaluationofalisbasedautoverificationsystemforcoagulationassaysinacoreclinicallaboratory
AT fanxia designandevaluationofalisbasedautoverificationsystemforcoagulationassaysinacoreclinicallaboratory
AT murunqing designandevaluationofalisbasedautoverificationsystemforcoagulationassaysinacoreclinicallaboratory
AT zhouliping designandevaluationofalisbasedautoverificationsystemforcoagulationassaysinacoreclinicallaboratory
AT hemiao designandevaluationofalisbasedautoverificationsystemforcoagulationassaysinacoreclinicallaboratory
AT qubo designandevaluationofalisbasedautoverificationsystemforcoagulationassaysinacoreclinicallaboratory